Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer

BACKGROUND: The aim of this randomized controlled study was to determine whether octreotide (OCT) or scopolamine butylbromide (SB) was the more effective antisecretive drug controlling gastrointestinal (GI) symptoms due to malignant bowel obstruction (MBO) caused by advanced ovarian cancer. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Xingang, Wang, Peige, Li, Shikuan, Zhang, Guangyong, Hu, Sanyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372044/
https://www.ncbi.nlm.nih.gov/pubmed/25889313
http://dx.doi.org/10.1186/s12957-015-0455-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372044/
https://www.ncbi.nlm.nih.gov/pubmed/25889313
http://dx.doi.org/10.1186/s12957-015-0455-3

Ejemplares similares